Authors
Latest:
Take-Home Messages for the Management of Crohn’s DiseaseExperts in gastroenterology share advice for the treatment of patients of Crohn’s disease.
Latest:
Future Directions in the Management of Ulcerative ColitisDrs. Maia Kayal and David P. Hudesman discuss their hopes and future directions in the treatment of patients with ulcerative colitis.
Latest:
Patient Education of HCMExpert cardiologists share strategies for educating patients on the treatment and management of hypertrophic cardiomyopathy.
Latest:
Does Aggressive or Moderate Fluid Resuscitation Better Treat Acute Pancreatitis?A recent randomized controlled trial showed the limitations of either option, despite being a cornerstone of care.
Latest:
Managing Glaucoma During COVID-19: Patients Point the Way to Improved CareA new survey assessed patients’ confidence in their disease management during the pandemic, specific disease management concerns, and experiences with telemedicine.
Latest:
Optimizing Care for ADHD During COVID-19Optimizing care and managing challenges for patients with ADHD during the COVID-19 pandemic and advice for clinicians educating patients and families on disease management.
Latest:
Introducing the Concoff Method: The Interface Between Sports Medicine and RheumatologyIn today's issue of Rheumatology Network, we introduce The Concoff Method, a new column by Andrew Concoff, M.D., a rheumatologist who serves as executive vice president and chief value medical officer of United Rheumatology. Over the course of the next year, Dr. Concoff will publish columns that address sports medicine, value in rheumatology and managing a medical practice in the era of COVID-19. In this inaugural issue of the column, he covers the interface between sports medicine and rheumatology.
Latest:
Take-Home Messages for the Management of Crohn’s DiseaseExperts in gastroenterology share advice for the treatment of patients of Crohn’s disease.
Latest:
Final Thoughts on the Opioid Crisis and Normalizing NaloxoneThe multidisciplinary panel of experts share final thoughts on strategies to normalize naloxone and decrease barriers to its obtainment and utilization.
Latest:
Access and Treatment of Insomnia in Primary Care ClinicsAn expert in sleep medicine highlights challenges in prescribing DORAs and importance of discussing insomnia with patients in the primary care setting.
Latest:
Clinical Pearls for the Management of IPFSteven D. Nathan, MD, FCCP, and Fernando J. Martinez, MD, MS, share clinical pearls and advice for the management of IPF.
Latest:
Practice Pearls for the Management of SCDA panel of experts in hematology discuss the future directions for sickle cell disease and share practice pearls for disease management.
Latest:
Care Collaboration in Atopic DermatitisExperts in dermatology discuss patient education and clinical pearls to assist colleagues in the management of atopic dermatitis.
Latest:
Assessing the Draft Revised CDC Clinical Practice Guideline for Prescribing Opioids 2022The Director of Policy and Advocacy for the US Pain Foundation addresses the important changes made to the updated draft of the CDC Clinical Practical Guideline for Prescribing Opioids 2022.
Latest:
The Race to the First RSV Vaccine: How Close Are We, and Why Has It Been so Difficult?Why has this season brought an unprecedented number of severe RSV infections, and why is vaccine development taking so long?
Latest:
Prioritizing Sleep Health From a Public Health StandpointThe past year has provided great steps forward in sleep science, and coupled with the lingering difficulties in care and the COVID-19 pandemic’s effects, the field is coming to a head to make sleep health a public health priority.
Latest:
Challenges in Managing Type 1 Diabetes and Pressing Need for New TherapiesDrs Diana Isaacs and Natalie Bellini discuss the everyday challenges of managing type 1 diabetes and underscore the need for new treatments to improve the quality of life for people living with type 1 diabetes
Latest:
Treatment Decisions and its Relation to Patient AccessibilityFinal thoughts from expert KOLs regarding treatment decisions and how they relate to patient accessibility when manage dyslipidemia.
Latest:
Improving Awareness for Depressive DisordersAndrew J Cutler, MD; Gregory Mattingly, MD; and Sagar V. Parikh, MD, FRCPC, comment on the need to improve awareness around depressive disorders and break the stigma of mental health treatment.
Latest:
Helping Your Patients Avoid the Migraine Trigger TrapForget what you think you know about red wine or chocolate ‘activating’ migraine. Many commonly accepted “triggers” aren’t triggers at all.
Latest:
Final Thoughts on the Opioid Crisis and Normalizing NaloxoneThe multidisciplinary panel of experts share final thoughts on strategies to normalize naloxone and decrease barriers to its obtainment and utilization.
Latest:
Reducing the Stigma of Unplanned Pregnancy Starts with a ConversationAn unplanned pregnancy can translate into a multitude of health factors and risks for both the mother and the baby.
Latest:
Quantifying the Association Between Anxiety and Depressive Features and High Disease Activity Scores in SLEAnxiety and depression can limit engagement with healthcare or treatment leading to later diagnosis, poor treatment adherence, and poor disease control with associated negative sequelae.
Latest:
Helpful Hints for Use of Biosimilars in Ophthalmology PracticesDr Peter Kaiser shares helpful hints for patient communication and for including biosimilars in clinical practice.
